Notifiable Condition (Agent) | Laboratory Confirmation Required Before Submitting Case Report | Time Frame for Notification from Identification of a Case | Who Must Be Notified | Who Must Report: Health Care Providers (Providers) or Health Care Facilities (Facilities) |
Acquired immunodeficiency syndrome (AIDS) | | Within 3 business days | DOH (for facilities) and LHJ (for providers) | Both |
Amebic meningitis | | Immediately | LHJ | Both |
Anaplasmosis | | Within 3 business days | LHJ | Both |
Anthrax (Bacillus anthracis and confirmed Bacillus cereus biovar anthracis only - Do not report all Bacillus cereus) | Yes | Immediately | LHJ | Both |
Arboviral disease (acute disease only) including, but not limited to: Chikungunya Dengue Eastern and western equine encephalitis Japanese encephalitis La Crosse encephalitis Powassan virus infection St. Louis encephalitis West Nile virus infection Zika virus infection See also "Yellow fever" | | Within 3 business days | LHJ | Both |
Asthma, occupational | | Within 30 days | Washington state department of labor and industries (L&I) | Both |
Babesiosis | | Within 3 business days | LHJ | Both |
Baylisascariasis | | Within 24 hours | LHJ | Both |
Birth defects - Abdominal wall defects (inclusive of gastroschisis and omphalocele) | | Within 30 days | DOH | Facilities |
Birth defects - Autism spectrum disorders | | Within 30 days | DOH | Both |
Birth defects - Cerebral palsy | | Within 30 days | DOH | Both |
Birth defects - Down syndrome | | Within 30 days | DOH | Facilities |
Birth defects - Alcohol related birth defects | | Within 30 days | DOH | Both |
Birth defects - Hypospadias | | Within 30 days | DOH | Facilities |
Birth defects - Limb reductions | | Within 30 days | DOH | Facilities |
Birth defects - Neural tube defects (inclusive of anencephaly and spina bifida) | | Within 30 days | DOH | Facilities |
Birth defects - Oral clefts (inclusive of cleft lip with/without cleft palate) | | Within 30 days | DOH | Facilities |
Blood lead level RST results | | Providers and facilities performing blood lead level RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. |
Botulism, foodborne, infant, and wound | | Immediately | LHJ | Both |
Brucellosis | | Within 24 hours | LHJ | Both |
Campylobacteriosis | | Within 3 business days | LHJ | Both |
| | | | |
Candida auris infection or colonization | | Within 24 hours | LHJ | Both |
Carbapenem-resistant Enterobacteriaceae infections limited to: Klebsiella species E. coli Enterobacter species | Yes | Within 3 business days | LHJ | Both |
Chagas disease | | Within 3 business days | LHJ | Both |
Chancroid | | Within 3 business days | LHJ | Both |
Chlamydia trachomatis infection | Yes | Within 3 business days | LHJ | Both |
Cholera (Vibrio cholerae O1 or O139) | Yes | Immediately | LHJ | Both |
Coccidioidomycosis | | Within 3 business days | LHJ | Both |
Coronavirus infection (severe communicable) SARS-associated coronavirus MERS-associated coronavirus Novel coronavirus (COVID-19) | Yes | Immediately | LHJ | Both |
Coronavirus infection (severe communicable) Novel coronavirus (COVID-19) RST results | | Providers and facilities performing Novel coronavirus (COVID-19) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. |
Cryptococcus gattii or undifferentiated Cryptococcus species (i.e., Cryptococcus not identified as C. neoformans) | Yes | Within 3 business days | LHJ | Both |
Cryptosporidiosis | | Within 3 business days | LHJ | Both |
Cyclosporiasis | | Within 3 business days | LHJ | Both |
Cysticercosis | | Within 3 business days | LHJ | Both |
Diphtheria | | Immediately | LHJ | Both |
Domoic acid poisoning | | Immediately | LHJ | Both |
E. coli (See "Shiga toxin-producing E. coli") | | | | |
Echinococcosis | | Within 3 business days | LHJ | Both |
Ehrlichiosis | | Within 3 business days | LHJ | Both |
Giardiasis | | Within 3 business days | LHJ | Both |
Glanders (Burkholderia mallei) | Yes | Immediately | LHJ | Both |
Gonorrhea | | Within 3 business days | LHJ | Both |
Granuloma inguinale | | Within 3 business days | LHJ | Both |
Gunshot wounds (nonfatal) | | Within 30 days | DOH | Facilities |
Haemophilus influenzae (invasive disease, children under 5 years of age) | Yes | Immediately | LHJ | Both |
Hantaviral infection | | Within 24 hours | LHJ | Both |
Hepatitis A (acute infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis B (acute infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers) | Yes | Within 3 business days | LHJ | Both |
Hepatitis B (chronic infection) - Initial diagnosis, and previously unreported prevalent cases | Yes | Within 3 business days | LHJ | Both |
Hepatitis B (perinatal) - Initial diagnosis, and previously unreported cases | Yes | Within 3 business days | LHJ | Both |
Hepatitis C (acute infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis C (acute infection) RST results | | Providers and facilities performing hepatitis C (acute infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. |
Hepatitis C (chronic infection) | Yes | Within 3 business days | LHJ | Both |
Hepatitis C (perinatal) - Initial diagnosis, and previously unreported cases | Yes | Within 24 hours | LHJ | Both |
Hepatitis C (chronic infection) RST results | | Providers and facilities performing hepatitis C (chronic infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. |
Hepatitis D (acute and chronic infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis E (acute infection) | Yes | Within 24 hours | LHJ | Both |
Herpes simplex, neonatal and genital (initial infection only) | | Within 3 business days | LHJ | Providers |
Histoplasmosis | | Within 3 business days | LHJ | Both |
Human immunodeficiency virus (HIV) infection | | Within 3 business days | LHJ | Both |
Human immunodeficiency virus (HIV) infection RST results | | Providers and facilities performing HIV infection RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. |
Human prion disease | | Within 3 business days | LHJ | Both |
Hypersensitivity pneumonitis, occupational | | Within 30 days | L&I | Both |
Influenza, novel or unsubtypable strain | | Immediately | LHJ | Both |
Influenza-associated death (laboratory confirmed) | Yes | Within 3 business days | LHJ | Both |
Legionellosis | | Within 24 hours | LHJ | Both |
Leptospirosis | | Within 24 hours | LHJ | Both |
Listeriosis | | Within 24 hours | LHJ | Both |
Lyme disease | | Within 3 business days | LHJ | Both |
Lymphogranuloma venereum | | Within 3 business days | LHJ | Both |
Malaria | | Within 3 business days | LHJ | Both |
Measles (rubeola) - Acute disease only | | Immediately | LHJ | Both |
Melioidosis (Burkholderia pseudomallei) | Yes | Immediately | LHJ | Both |
Meningococcal disease, invasive | | Immediately | LHJ | Both |
Monkeypox | | Immediately | LHJ | Both |
Mumps, acute disease only | | Within 24 hours | LHJ | Both |
Outbreaks and suspected outbreaks | | Immediately | LHJ | Both |
Paralytic shellfish poisoning | | Immediately | LHJ | Both |
Pertussis | | Within 24 hours | LHJ | Both |
Pesticide poisoning (hospitalized, fatal, or cluster) | | Immediately | DOH | Both |
Pesticide poisoning (all other) | | Within 3 business days | DOH | Both |
Plague | | Immediately | LHJ | Both |
Poliomyelitis | | Immediately | LHJ | Both |
Pregnancy in patient with hepatitis B virus | | See "Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers)" |
Psittacosis | | Within 24 hours | LHJ | Both |
Q fever | | Within 24 hours | LHJ | Both |
Rabies (suspect or laboratory confirmed human cases and laboratory confirmed animal cases) | Yes for animal cases | Immediately | LHJ | Both |
Rabies, suspected human exposure (suspected human rabies exposures due to a bite from or other exposure to an animal that is suspected of being infected with rabies) | | Immediately | LHJ | Both |
Relapsing fever (borreliosis) | | Within 3 business days | LHJ | Both |
Rickettsia infection | | Within 3 business days | LHJ | Both |
Rubella, acute disease only (including congenital rubella syndrome) | | Immediately | LHJ | Both |
Salmonellosis | | Within 24 hours | LHJ | Both |
Serious adverse reactions to immunizations | | Within 3 business days | LHJ | Both |
Shiga toxin-producing E. coli (STEC) infections/enterohemorrhagic E. coli infections | Yes | Immediately | LHJ | Both |
Shigellosis | | Within 24 hours | LHJ | Both |
Silicosis | | Within 30 days | L&I | Both |
Smallpox | | Immediately | LHJ | Both |
Syphilis | | Within 3 business days | LHJ | Both |
Taeniasis | | Within 3 business days | LHJ | Both |
Tetanus | | Within 3 business days | LHJ | Both |
Tick paralysis | | Within 3 business days | LHJ | Both |
Trichinosis | | Within 3 business days | LHJ | Both |
Tuberculosis disease (confirmed or highly suspicious, i.e., initiation of empiric treatment) | | Within 24 hours | LHJ | Both |
Tularemia | | Immediately | LHJ | Both |
Typhus | | Within 3 business days | LHJ | Both |
Vaccinia transmission | | Immediately | LHJ | Both |
Vancomycin-resistant Staphylococcus aureus (not to include vancomycin-intermediate) | Yes | Within 24 hours | LHJ | Both |
Varicella-associated death | | Within 3 business days | LHJ | Both |
Vibriosis (Vibrio species not including Vibrio cholerae O1 or O139) See Cholera (Vibrio cholerae O1 or O139) | Yes | Within 24 hours | LHJ | Both |
Viral hemorrhagic fever | | Immediately | LHJ | Both |
Yellow fever | | Immediately | LHJ | Both |
Yersiniosis | | Within 24 hours | LHJ | Both |
Unexplained critical illness or death | | Within 24 hours | LHJ | Both |